期刊文献+

成人H3 K27M基因突变型弥漫中线胶质瘤一例报道并文献复习 被引量:1

Adult H3 K27M mutant diffuse midline glioma:one case report and literature review
原文传递
导出
摘要 组蛋白H3 K27M基因突变型弥漫中线胶质瘤是2016年版世界卫生组织(WHO)中枢神经系统肿瘤分类标准中新增的胶质瘤分类,其特点是H3 K27M特定位点突变及好发于中线部位,属高度恶性肿瘤,多见于儿童,偶见成人。目前对H3 K27M突变型弥漫中线胶质瘤诊治的报道较少,空军军医大学西京医院神经外科曾收治1例成人H3 K27M突变型弥漫中线胶质瘤患者,现将该患者的诊治经过报道如下。
作者 王凯 邹鹏 李骜 李三中 Wang Kai;Zou Peng;Li Ao;Li Sanzhong
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2020年第2期194-196,共3页 Chinese Journal of Neuromedicine
  • 相关文献

参考文献4

二级参考文献20

  • 1Liang D, Schulder M. The role of intraoperative magnetic resonance imaging in glioma surgery [ J ] . Surg Neurol Int, 2012, 3 ( Suppl 4 ): S320-S327.
  • 2Stupp R, Mason WP, Van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J]. NEngl J Med, 2005, 352 ( 10 ) : 987-996.
  • 3Hau P, Koch D, Hundsberger T, et al. Safety and feasibility of long- term temozolomide treatment in patients with high-grade glioma [ J ] . Neurology, 2007, 68 ( 9 ) : 688-690.
  • 4Khasraw M, Bell D, Wheeler H. Long-term use of temozolomide : could you use temozolomide safely for Life in gliomas? [ J ] . J Clin Neurosci, 2009, 16 ( 6 ) : 854-855.
  • 5Seiz M, Krafft U, Freyschlag CF, et al. Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme : experience of a single institution [ J ] . J Cancer Res Clin Oncol, 2010, 136 ( 11 ) : 1691-1695.
  • 6Darlix A, Banmann C, Lorgis V, et al. Prolonged administration of adjuvant temozolomidc improves survival in adult patients with glioblastoma [ J ] . Anticancer Res, 2013, 33 ( 8 ) : 3467-3474.
  • 7Mannas JP, Lightner DD, Defrates SR, et at. Long-term treatment with temozolomide in malignant glioma [ J ] . J Clin Neurosci, 2014, 21 ( 1 ) : 121-123.
  • 8Galldiks N, Kracht LW, Burghaus L, et at. Patient-tailored, imaging-guided, tong-term temozolomide chemotherapy in patients with glioblastoma [ J ] . Mol Imaging, 2010, 9 ( 1 ) : 40-46.
  • 9Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial[ J ]. Lancet Oncol, 2009, 10( 5 ): 459-466.
  • 10Chen C, Xu T, Lu Y, et at. The efficacy of temozolomide for recurrent glioblastoma muhiforme [ J ]. Eur J Neurol, 2013, 20 ( 2 ) : 223- 230.

共引文献60

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部